Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020

Description:

iGATE Research report titled Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020 is a 213 page report with 26 Figures and 25 Tables. This report studies in detail the Global Cancer Vaccines Market, Regional Cancer Vaccines Market, Major Deals and Funding in Cancer Vaccines Industry, Cancer Vaccines Pipeline Products Portfolio, Company Wise Cancer Vaccines Pipeline Products and the driving factors and challenges for the Cancer Vaccines Market. – PowerPoint PPT presentation

Number of Views:123

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global - Cancer Vaccines Market and Pipeline Vaccines Analysis to 2020


1
(No Transcript)
2
Global Cancer Vaccines Market - Overview
The cancer industry is one of the most lucrative
business worldwide. Cancer vaccines are a viable
option for treating many types of cancers which
in the present day do not have effective
treatments. Cancer vaccines can be broadly
classified into two segments prophylactic and
therapeutic vaccines. Prophylactic vaccines are
used for the prevention of cancer, whereas
therapeutic vaccines are used for treatment of
cancer. With the rising incidences of cancer and
limited treatment options, physicians are being
forced to look for precautionary vaccines beyond
the conventional treatments. As a result, many
companies are now investing in developing
prophylactic and therapeutic vaccines to curb
this deadly disease.
3
Continue (www.igateresearch.com)
The prophylactic vaccines currently available in
the market include Merck's Gardasil and GSK's
Cervarix while the only therapeutic vaccine in
the market is Dendreon's Provenge. In the global
cancer vaccines market, the prophylactic vaccines
segment account for maximum share of the market.
However, the market share of prophylactic
vaccines is likely to decline continuously during
the forecasting period due to the increasing
uptake of therapeutic vaccines. The market share
of therapeutic cancer vaccines is anticipated to
increase during the forecasting period. In the
cancer vaccines market, Merck is the clear leader
and is expected to maintain its dominancy over a
longer period of time. Dendreon Corporation is
the second leading player in Cancer vaccines
market accounting for XX market share in 2014.
It is predicted that GSK will account for single
digit share of the cancer vaccine market by 2020.
4
Global Cancer Vaccines Market - Regional Analysis
The United States is the largest regional market
for cancer vaccines. United States accounted for
XX share of the global cancer vaccines market in
2014. The Asian region is the second leading
market for cancer vaccines. The European region
cancer vaccines market share is anticipated to
increase from XX in 2014 to XX by the year 2020.
5
Continue (www.igateresearch.com)
iGATE Research report titled Global - Cancer
Vaccines Market and Pipeline Vaccines Analysis to
2020 is a 213 page report with 26 Figures and 25
Tables. This report analyses the Global Cancer
Vaccines Market, Regional Cancer Vaccines Market,
Major Deals and Funding in Cancer Vaccines
Industry, Cancer Vaccines Pipeline Products
Portfolio, Company Wise Cancer Vaccines Pipeline
Products and the driving factors and challenges
for the Cancer Vaccines Market.
6
Cancer Vaccines Market studied in the report
covers the following 7 points
1. Global - Prophylactic Cancer Vaccines Market
to 2020 Gardasil Cervarix 2. Global -
Therapeutic Cancer Vaccines Market to 2020
Provenge 3. Cancer Vaccines Market - Regional
Analysis to 2020 United States - Cancer
Vaccines Market Europe - Cancer Vaccines
Market Asia - Cancer Vaccines Market 4.
Global Cancer Vaccines Market - Major Deals 5.
Global Cancer Vaccines - Funding 6. Global Cancer
Vaccines Market - Pipeline Portfolio Analysis 7.
Company Cancer Vaccines - Pipeline Analysis
7
The 12 Cancer Vaccines Pipeline Portfolio covered
in the report are as follows
1.    Prostvac 7.    Talimogene Laherparepvec
2.    Neuvax 8.    IMA901
3.    Rindopepimut 9.    Imprime PGG
4.    MVax 10. OncoVAX
5.    DCVax-L 11. Lucanix
6.    ProstAtak 12. DCVAC/PCa
8
34 Companies Pipeline Cancer Vaccines covered in
the reports are as follows
1.    Aduro Biotech 13. Galena Biopharma 25. NovaRx
2.    Advantagene 14. Genexine 26. OncoThyreon
3.    Advaxis 15. GlobeImmune 27. Oncovir
4.    Agenus 16. Gradalis 28. Oxford BioMedica
5.    AlphaVax 17. Heat Biologics 29. Prima BioMed
6.    Altor BioScience 18. Immatics 30. Sotio
7.    Argos Therapeutics 19. ImmunoCellular Therapeutics 31. Transgene
8.    AVAX Technologies 20. Inovio Pharmaceuticals 32. Ubivac
9.    Bavarian Nordic 21. ISA Pharmaceuticals 33. Vaccinogen
10. Biothera 22. Juvaris Biotherapeutics 34. Vaxon Biotech
11. Celldex Therapeutics 23. NewLink Genetics  
12. CureVac 24. Northwest Biotherapeutics  
9
Published By
iGATE RESEARCH Phone 91-858-684-0791
(India) 91-706-527-9335 (India)
Email info_at_igateresearch.com Internet
www.igateresearch.com          
10
Format
Report Title Global - Cancer Vaccines Market and
Pipeline Vaccines Analysis to 2020 To Order the
Report Visit http//www.igateresearch.com/Product
Detail.php?pd_nameGlobal20-20Cancer20Vaccines
20Market20and20Pipeline20Vaccines20Analysis20
to202020
Single User License US 1,290
Hard-copy Mail Delivery US 1,450
CD-ROM Mail Delivery US 1,400
Multi User License US 1,800
11
Order the Report
iGATE RESEARCH PVT. LTD. Web www.igateresearch.c
om To order the Report E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA) For
Report Related Query E-Mail 
ravi.sinha_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA)
About PowerShow.com